SCHEMBL30484231

SCHEMBL30484231

OCc1cccc(-c2cccnc2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.68
MKNK2 Q9HBH9 2/20 0.68
PRKCI P41743 1/20 0.68
EPHX2 P34913 1/20 0.63
PRMT6 Q96LA8 1/20 0.63
FYN P06241 1/20 0.57
CYP2A6 P11509 5/20 0.56
ALDH1A1 P00352 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
MEN1 O00255 1/20 0.55
PSIP1 O75475 1/20 0.55
AXL P30530 1/20 0.55
KMO O15229 1/20 0.53
BACE1 P56817 1/20 0.51
ABCG2 Q9UNQ0 1/20 0.49
CYP11B1 P15538 3/20 0.49
CYP11B2 P19099 3/20 0.49
CYP19A1 P11511 2/20 0.49
CYP17A1 P05093 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4581739 1.00 MKNK1 (0.68) MKNK1MKNK2PRKCIEPHX2PRMT6
SCHEMBL9455151 0.93 MKNK1 (0.60) MKNK1MKNK2PRKCIEPHX2PRMT6
SCHEMBL16996659 0.87 MKNK1 (0.70) MKNK1MKNK2PRKCIEPHX2PRMT6
SCHEMBL9454416 0.86 MKNK1 (0.55) MKNK1MKNK2PRKCIEPHX2PRMT6
SCHEMBL9454404 0.86 MKNK1 (0.55) MKNK1MKNK2PRKCIEPHX2PRMT6
SCHEMBL9454544 0.86 MKNK1 (0.55) MKNK1MKNK2PRKCIEPHX2PRMT6
SCHEMBL1139185 0.86 EPHX2 (0.59) MKNK1MKNK2PRKCIEPHX2PRMT6
SCHEMBL844549 0.85 MKNK1 (0.68) MKNK1MKNK2PRKCIEPHX2PRMT6
SCHEMBL12241292 0.83 PRKCI (0.65) MKNK1MKNK2PRKCIEPHX2PRMT6
SCHEMBL4191589 0.82 PRKCI (0.72) PRKCIFYNCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023069700-A1 COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF MONTE ROSA THERAPEUTICS, INC. (US) 2023-04-27 WO disclosed